Why Is Kazia Therapeutics Stock Down Today?
Kazia's initial offering announcement removed pricing certainty; the next-day terms separated $40 million of upfront proceeds from contingent warrants.
- KZIA fell when the proposed offering arrived without final size or price.
- The next-day pricing established $40 million of expected upfront gross proceeds.
- The $120 million headline requires warrant exercises and is not all committed cash.
16:09:00 ET
Reaction by asset (real prices)
| Asset | 2m before | At release | +1m | +15m | +1m % | +15m % | Vol vs normal |
|---|---|---|---|---|---|---|---|
| KZIA | 16.49 | 16.49 | 14.00 | 12.98 | -15.10% | -21.29% | — |
Kazia Therapeutics shares fell 21.286% in the first 15 minutes after its proposed public offering crossed on Thursday, August 27, 2026, at 4:09:00 p.m. ET. MoveSurge measured KZIA from $16.49 before the event to $12.98 15 minutes later because the initial announcement introduced new issuance without final pricing or size.
The next morning converted that uncertainty into terms. Kazia priced the base transaction for approximately $40 million of gross proceeds at $15.50 per ADS and accompanying warrants. The larger $120 million headline includes contingent warrant proceeds and should not be read as cash committed at closing.
How is Kazia's offering structured?
| Component | Term |
|---|---|
| Base offering | 2,580,000 ADSs or equivalents |
| Package price | $15.50 per ADS and warrants |
| Expected upfront gross proceeds | $40 million |
| Series A warrant price | $17.825 |
| Series B warrant price | $19.375 |
| Maximum headline amount | Up to $120 million with warrant exercises |
The warrants are tied to future clinical-data windows as well as outside expiration dates. Their exercise requires the share price and holder economics to support payment. That makes the additional capital conditional on future events.
What did the two KZIA reactions show?
The proposed offering moved KZIA from $16.49 to $14.00 in one minute, a 15.1% decline. The price reached $12.98 after 15 minutes on 242,578 measured shares.
When pricing crossed the next morning, MoveSurge measured KZIA from $14.21 to $15.00, a 5.559% gain that held through minute 15. The partial rebound shows the value of certainty: the final $15.50 package price was above the second event's pre-headline market level, although it did not erase the earlier repricing.
Kazia public offering reaction measured
The sequence separates two questions. The first announcement raised dilution and supply uncertainty. The pricing announcement fixed the upfront proceeds and package price, while leaving the larger warrant-dependent amount for later.
This article describes historical reactions and sourced offering documents. It does not predict KZIA's future price or clinical outcomes.
Why is KZIA stock down after the public offering announcement?
KZIA fell 21.286% in MoveSurge's first 15-minute window because the proposed offering initially lacked final price and size, increasing uncertainty about new share supply.
How much cash is Kazia raising up front?
The priced base offering is expected to produce approximately $40 million of gross proceeds before expenses. The $120 million headline depends on future warrant exercises.
What price did Kazia set for the offering?
Kazia priced each ADS and accompanying warrant package at $15.50. The later pricing headline produced a measured 5.559% gain from $14.21 to $15.00.
Sources
-
https://www.kaziatx.com/investors/news-and-events/press-releases/detail/217/kazia-therapeutics-limited-announces-proposed-public-offering
— Kazia Therapeutics
Proposed tranched offering structure, warrant design, and intended use of proceeds.
-
https://www.kaziatx.com/media-center/news/detail/218/kazia-therapeutics-limited-announces-pricing-of-up-to-120-million-public-offering
— Kazia Therapeutics
Final package price, base offering size, expected gross proceeds, and warrant quantities.
-
https://www.sec.gov/Archives/edgar/data/1075880/000121390026094600/ea0303789-424b5_kazia.htm
— U.S. Securities and Exchange Commission
Filed prospectus terms and warrant exercise prices.
Never miss the next market-moving story
Seven market specialists, with experience dating back to 2006, watch global markets and U.S. stocks of every size. Start Pro to get the full live feed, clear context, measured price moves, search, watchlists, and alerts.
Start Pro — $29 for 7 days Watch KZIA live -- free